The neurotransmitter acetylcholine (ACh) promotes the growth and metastasis of several cancers via its M3 muscarinic receptor (M3R). Metastasis-associated in colon cancer-1 (MACC1) is an oncogene that is overexpressed in gastric cancer (GC) and plays an important role in GC progression, though it is unclear how MACC1 activity is regulated in GC. In this study, we demonstrated that ACh acts via M3Rs to promote GC cell invasion and migration as well as expression of several markers of epithelial-mesenchymal transition (EMT). The M3R antagonist darifenacin inhibited GC cell activity in both the presence and absence of exogenous ACh, suggesting GC cells secrete endogenous ACh, which then acts in an autocrine fashion to promote GC cell migration/invasion. ACh up-regulated MACC1 in GC cells, and MACC1 knockdown using siRNA attenuated the effects of ACh on GC cells. AMP-activated protein kinase (AMPK) served as an intermediate signal between ACh and MACC1. These findings suggest that ACh acts via a M3R/AMPK/MACC1 signaling pathway to promote GC cell invasion/migration, which provides insight into the mechanisms underlying GC growth and metastasis and may shed light on new targets for GC treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951273 | PMC |
| http://dx.doi.org/10.18632/oncotarget.7634 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The alarmin, interleukin-33, increases vascular tone via extracellular signal regulated kinase-mediated Ca sensitization and endothelial nitric oxide synthase inhibition.
J Physiol
November 2024
Department of Physiology, Pharmacology & Toxicology, Health Sciences Center, West Virginia University, Morgantown, WV, USA.
Alarmins are classified by their release from damaged or ruptured cells. Many alarmins have been found to increase vascular tone and oppose endothelium-dependent dilatation (EDD). Interleukin (IL)-33 plays a prominent role in lung injury and can be released during vascular injury and in chronic studies found to be cardioprotective.
View Article and Find Full Text PDFAI-Enabled Ultra-large Virtual Screening Identifies Potential Inhibitors of Choline Acetyltransferase for Theranostic Purposes.
ACS Chem Neurosci
November 2024
Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India.
Alzheimer's disease (AD) and related dementias are among the primary neurological disorders and call for the urgent need for early-stage diagnosis to gain an upper edge in therapeutic intervention and increase the overall success rate. Choline acetyltransferase (ChAT) is the key acetylcholine (ACh) biosynthesizing enzyme and a legitimate target for the development of biomarkers for early-stage diagnosis and monitoring of therapeutic responses. It is also a theranostic target for tackling colon and lung cancers, where overexpression of non-neuronal ChAT leads to the production of acetylcholine, which acts as an autocrine growth factor for cancer cells.
View Article and Find Full Text PDFAn endogenous cholinergic system controls electrical conduction in the heart.
Eur Heart J
October 2024
State Key Laboratory of Cardiovascular Diseases, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
Article Synopsis
- - The study investigates the presence and role of an intrinsic cholinergic system in the heart, which uses acetylcholine (ACh) to manage electrical conduction and its link to arrhythmias in humans and mice.
- - Researchers identified key components of this system, such as ACh receptors and transporters, showing that they significantly influence how electrical signals are conducted in heart cells.
- - Findings suggest that defects in this cholinergic system can lead to serious ventricular arrhythmias, highlighting new mechanisms for understanding heart rhythm disorders beyond traditional views.
Human iPSC-derived mesenchymal stem cells relieve high blood pressure in spontaneously hypertensive rats via splenic nerve activated choline acetyltransferase-positive cells.
Sci China Life Sci
October 2024
Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, 510080, China.
Article Synopsis
- - Despite advancements in medicine, hypertension treatment remains problematic, but recent research shows promise in using stem cell therapies, particularly mesenchymal stem cells (MSCs), for cardiovascular diseases.
- - This study found that injecting human induced pluripotent stem cell-derived MSCs (hiPSC-MSCs) significantly reduced blood pressure in hypertensive rats and revealed that these cells accumulate in the spleen and may interact with the splenic nerve.
- - The hiPSC-MSCs release glutamate, which activates the splenic sympathetic nerve, leading to increased norepinephrine release, enhancing choline acetyltransferase (ChAT) cell numbers, and ultimately contributing to lower blood pressure and reduced inflammation.
Oral complement factor D inhibitor danicopan for paroxysmal nocturnal hemoglobinuria.
Expert Rev Clin Pharmacol
September 2024
School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Article Synopsis
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder leading to hemolysis, thrombosis, and bone marrow failure, with danicopan (Voydeya™) recently approved for its treatment.
- A systematic review of studies on danicopan showcased its efficacy in increasing hemoglobin levels in patients with PNH, particularly highlighted in a phase 3 trial where 60% of participants saw significant improvement compared to none in the placebo group.
- Common side effects of danicopan include headaches and respiratory infections, and a vaccination before treatment is recommended to prevent bacterial infections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!